Manulife (Manufacturers Life Insurance)
CORT icon

Manulife (Manufacturers Life Insurance)’s Corcept Therapeutics CORT Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$974K Buy
24,158
+2,019
+9% +$75.5K ﹤0.01% 1846
2025
Q4 		$770K Buy
22,139
+903
+4% +$70.9K ﹤0.01% 1985
2025
Q3 		$1.76M Buy
21,236
+295
+1% +$21.3K ﹤0.01% 1575
2025
Q2 		$1.54M Sell
20,941
-30,036
-59% -$2.18M ﹤0.01% 1617
2025
Q1 		$5.82M Buy
50,977
+1,218
+2% +$74.1K 0.01% 1105
2024
Q4 		$2.51M Sell
49,759
-1,237
-2% -$64.8K ﹤0.01% 1472
2024
Q3 		$2.36M Buy
50,996
+2,216
+5% +$78.7K ﹤0.01% 1491
2024
Q2 		$1.58M Buy
48,780
+932
+2% +$25.5K ﹤0.01% 1585
2024
Q1 		$1.21M Buy
47,848
+5,240
+12% +$124K ﹤0.01% 1755
2023
Q4 		$1.38M Sell
42,608
-703
-2% -$19.3K ﹤0.01% 1644
2023
Q3 		$1.18M Buy
43,311
+10,073
+30% +$292K ﹤0.01% 1645
2023
Q2 		$740K Sell
33,238
-1,742
-5% -$40.1K ﹤0.01% 1813
2023
Q1 		$758K Buy
34,980
+73
+0.2% +$1.6K ﹤0.01% 1763
2022
Q4 		$709K Buy
34,907
+353
+1% +$8.85K ﹤0.01% 1782
2022
Q3 		$886K Sell
34,554
-553
-2% -$14.8K ﹤0.01% 1659
2022
Q2 		$835K Sell
35,107
-1,787
-5% -$38.9K ﹤0.01% 1729
2022
Q1 		$831K Sell
36,894
-12,253
-25% -$261K ﹤0.01% 1857
2021
Q4 		$973 Sell
49,147
-920
-2% -$18.7K ﹤0.01% 1841
2021
Q3 		$985K Sell
50,067
-5,063
-9% -$106K ﹤0.01% 1850
2021
Q2 		$1.21M Sell
55,130
-30
-0.1% -$668 ﹤0.01% 1876
2021
Q1 		$1.31M Sell
55,160
-3,302
-6% -$88.2K ﹤0.01% 1742
2020
Q4 		$1.53M Buy
58,462
+2,466
+4% +$52K ﹤0.01% 1630
2020
Q3 		$975K Sell
55,996
-1,675
-3% -$26.7K ﹤0.01% 1673
2020
Q2 		$966K Sell
57,671
-3,539
-6% -$49.7K ﹤0.01% 1636
2020
Q1 		$728K Buy
61,210
+3,352
+6% +$41.5K ﹤0.01% 1651
2019
Q4 		$700K Sell
57,858
-238,019
-80% -$3.31M ﹤0.01% 1861
2019
Q3 		$4.31M Buy
295,877
+234,219
+380% +$2.88M ﹤0.01% 1206
2019
Q2 		$687K Sell
61,658
-282,494
-82% -$3.15M ﹤0.01% 1855
2019
Q1 		$4.04M Buy
344,152
+314
+0.1% +$3.9K ﹤0.01% 1272
2018
Q4 		$4.59M Sell
343,838
-44,276
-11% -$585K 0.01% 1177
2018
Q3 		$5.44M Buy
388,114
+52,083
+15% +$728K 0.01% 1212
2018
Q2 		$5.28M Buy
336,031
+45,040
+15% +$784K 0.01% 1233
2018
Q1 		$4.79M Buy
290,991
+54,263
+23% +$1.01M 0.01% 1242
2017
Q4 		$4.28M Buy
236,728
+56,754
+32% +$1.03M ﹤0.01% 1270
2017
Q3 		$3.47M Sell
179,974
-1,440
-0.8% -$21.5K ﹤0.01% 1288
2017
Q2 		$2.14M Buy
181,414
+121,292
+202% +$1.32M ﹤0.01% 1428
2017
Q1 		$658K Buy
60,122
+7,114
+13% +$62.5K ﹤0.01% 1997
2016
Q4 		$385K Sell
53,008
-932
-2% -$7.3K ﹤0.01% 2291
2016
Q3 		$351K Buy
53,940
+103
+0.2% +$599 ﹤0.01% 2325
2016
Q2 		$294K Buy
53,837
+9,232
+21% +$48K ﹤0.01% 2406
2016
Q1 		$191K Buy
44,605
+937
+2% +$3.65K ﹤0.01% 2626
2015
Q4 		$217 Buy
43,668
+1,227
+3% +$5.53K ﹤0.01% 2597
2015
Q3 		$159 Hold
42,441
– – ﹤0.01% 2835
2015
Q2 		$255 Buy
42,441
+773
+2% +$4.74K ﹤0.01% 2656
2015
Q1 		$233 Buy
41,668
+313
+0.8% +$1.13K ﹤0.01% 2619
2014
Q4 		$124 Buy
41,355
+1,435
+4% +$4.38K ﹤0.01% 2966
2014
Q3 		$107 Buy
39,920
+37,913
+1,889% +$100K ﹤0.01% 3064
2014
Q2 		$6K Sell
2,007
-43,742
-96% -$129K ﹤0.01% 3483
2014
Q1 		$200 Buy
45,749
+4,341
+10% +$15.2K ﹤0.01% 2716
2013
Q4 		$133 Buy
41,408
+36,013
+668% +$72.8K ﹤0.01% 2953
2013
Q3 		$9 Sell
5,395
-1,505
-22% -$2.65K ﹤0.01% 3269
2013
Q2 		$12K Buy
+6,900
New +$12.4K ﹤0.01% 3158

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CORT Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Corcept Therapeutics (CORT) stake by 9.1% in Q1 2026, buying an estimated $75.5K and bringing the position to 24,158 shares worth $974K. The position accounts for ﹤0.01% of the portfolio, ranked #1846.

Manulife (Manufacturers Life Insurance) first reported a position in CORT in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.82M in Q1 2025. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 24,158 shares of Corcept Therapeutics worth $974K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 2,019 Corcept Therapeutics shares in Q1 2026, an estimated $75.5K.
  • Corcept Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1846 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Corcept Therapeutics in Q2 2013 and has held it in 52 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Corcept Therapeutics position peaked at $5.82M in Q1 2025.
  • 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.